Document Classification

Section Type: RESULTS

Text: Gastrointestinal adverse events were reported less frequently in azithromycin (18. 8 % ; 45 of 239) than in erythromycin estolate (41. 2 % ; 98 of 238) recipients (90 % CI on difference : -29. 0 % to -15. 7 %) as a result of less nausea (2. 9 % vs 8. 4 % ; 95 % CI : -8. 9 % to -2. 0 %), less vomiting (5. 0 % vs 13. 0 % ; 95 % CI : -4. 9 % to -1. 4 %), and less diarrhea (7. 1 % vs 11. 8 % ; 95 % CI : -9. 0 % to -0. 3 %).